| Timothy Andrew Ferenchick, MD | |
|
1000 Tuckerton Ct, Reading, PA 19605-1177 | |
| (610) 988-4000 | |
| (610) 988-4004 |
| Full Name | Timothy Andrew Ferenchick |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 1000 Tuckerton Ct, Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205892403 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD421513 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reading Hospital | 7618886490 | 102 |
News Archive
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
"Health care, taxes, energy, favorite flavor of ice cream - it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."
› Verified 1 days ago
| Entity Name | Reading Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194883306 PECOS PAC ID: 7618886490 Enrollment ID: O20031126000129 |
News Archive
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
"Health care, taxes, energy, favorite flavor of ice cream - it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."
› Verified 1 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
"Health care, taxes, energy, favorite flavor of ice cream - it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."
› Verified 1 days ago
| Entity Name | Reading Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992387518 PECOS PAC ID: 7618886490 Enrollment ID: O20040408001076 |
News Archive
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
"Health care, taxes, energy, favorite flavor of ice cream - it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."
› Verified 1 days ago
| Entity Name | Phoenixville Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891866182 PECOS PAC ID: 5799796850 Enrollment ID: O20060606000128 |
News Archive
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
"Health care, taxes, energy, favorite flavor of ice cream - it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."
› Verified 1 days ago
| Entity Name | Tower Health Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194293647 PECOS PAC ID: 2668716069 Enrollment ID: O20181211002273 |
News Archive
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
"Health care, taxes, energy, favorite flavor of ice cream - it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Andrew Ferenchick, MD Po Box 13579, Reading, PA 19612-3579 Ph: () - | Timothy Andrew Ferenchick, MD 1000 Tuckerton Ct, Reading, PA 19605-1177 Ph: (610) 988-4000 |
News Archive
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
"Health care, taxes, energy, favorite flavor of ice cream - it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."
› Verified 1 days ago
Dr. Robin E. Savar, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3970 Perkiomen Ave, Suite 102, Reading, PA 19606 Phone: 610-779-1330 Fax: 610-779-7699 | |
Mark Elliot Wagner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 623 North 5th Street, Reading, PA 19601 Phone: 610-374-8585 Fax: 610-374-2574 | |
Joseph Kang, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 131 N 5th St, Reading, PA 19601 Phone: 610-375-8507 Fax: 610-374-5249 | |
Dr. Thomas Hanz Noller, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 526 Penn St, Ste 2, Reading, PA 19602 Phone: 610-375-3000 Fax: 610-898-1149 | |
Leslie Marie Lazore-mack, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1903 Morgantown Rd, Reading, PA 19607 Phone: 610-777-4040 Fax: 610-777-5575 | |
Pearl N Pakdi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2500 Bernville Rd, Reading, PA 19605 Phone: 610-378-2000 Fax: 610-378-2799 | |
Claire Murphy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 400 Saint Bernardine St, Alvernia University, Health & Wellness Center, Veronica, Reading, PA 19607 Phone: 610-568-1467 Fax: 610-796-8422 |